Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
10.1016/j.nut.2014.10.001 57 LeeJ.WolfgangM
Largest market, led by the US, with high adoption of branded GLP-1 drugs, strong payer coverage, and a robust pipeline
Alcohol Use Disorder: A study published in Translational Psychiatry found that GLP-1 receptor agonists reduced alcohol consumption in animal models of alcohol use disorder
With more people taking GLP-1s for weight-loss, its becoming clear that these people must take certain steps to maintain their health alongside the medication use
However, this normalization comes with concerns
US$ 28.14
US$ 25.41
US$ 24.42
US$ 23.75
